Literature DB >> 21781265

Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.

Y Fujimura1, M Matsumoto, A Isonishi, H Yagi, K Kokame, K Soejima, M Murata, T Miyata.   

Abstract

Upshaw-Schulman syndrome (USS) is an extremely rare hereditary deficiency of ADAMTS13 activity, termed congenital TTP. The clinical signs are usually mild during childhood, often with isolated thrombocytopenia. But their symptoms become more evident when patients have infections or get pregnant. We identified 43 USS-patients in Japan, who ranged in age from early childhood to 79 years of age. Analysing the natural history of these USS patients based on ADAMTS13 gene mutations may help characterise their clinical phenotypes. Severe neonatal jaundice that requires exchange blood transfusion, a hallmark of USS, was found in 18 of 43 patients (42%). During childhood, 25 of 43 patients were correctly diagnosed with USS without gender disparity. These 25 patients were categorised as having 'the early-onset phenotype'. Between 15 and 45 years of age, 15 were correctly diagnosed, and, interestingly, they were all female. The remaining three patients were male and were diagnosed when they were older than 45 years of age, suggesting that they were 'the late-onset phenotype'. Two of these three males developed sudden overt TTP when they were 55 and 63 years old, respectively. These two men had two different homozygous ADAMTS13 gene mutations, p.R193W/p.R193W and p.C1024R/p.C1024R, respectively. Both of which were not discovered in the US or Western countries. In vitro expression studies showed that these two proteins were consistently secreted into the culture medium but to a lesser extent and with reduced activity compared to the wild-type protein. Our results indicate that 'the late-onset phenotype' of USS is formed with ethnic specificity.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781265     DOI: 10.1111/j.1538-7836.2011.04341.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  43 in total

1.  [A 2-day-old neonate with hyperbilirubinemia and thrombocytopenia].

Authors:  Chen Li; Zheng Chen; Ming-Yan Chen; Xiao-Lu Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  A first bout of thrombotic thrombocytopenic purpura triggered by herpes simplex infection in a 45-year-old nulliparous female with Upshaw-Schulman syndrome.

Authors:  Masanobu Morioka; Masanori Matsumoto; Makoto Saito; Koichi Kokame; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

Review 3.  The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective.

Authors:  James N George
Journal:  Blood Adv       Date:  2018-06-26

4.  Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2016-09-13       Impact factor: 22.113

5.  Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura.

Authors:  Hayley A Hanby; X Long Zheng
Journal:  Hereditary Genet       Date:  2014

Review 6.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

7.  Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura.

Authors:  Liang Zheng; Yingying Mao; Mohammad S Abdelgawwad; Nicole K Kocher; Mandy Li; Xiangrong Dai; Benjamin Li; X Long Zheng
Journal:  Blood Adv       Date:  2016-11-29

8.  Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome.

Authors:  Yoshihiro Fujimura; Bernhard Lämmle; Saori Tanabe; Kazuya Sakai; Toshiyuki Kimura; Koichi Kokame; Toshiyuki Miyata; Yukihiro Takahashi; Shigeki Taniguchi; Masanori Matsumoto
Journal:  Blood Adv       Date:  2019-11-12

9.  First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene.

Authors:  Sheng-Chieh Chou; Dong-Tasmn Lin; Ching-Yeh Lin; Ying-Chih Huang; Han-Ni Hsieh; Ming-Ching Shen
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

10.  Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.

Authors:  Wenjing Cao; Huy P Pham; Lance A Williams; Jenny McDaniel; Rance C Siniard; Robin G Lorenz; Marisa B Marques; X Long Zheng
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.